Target intelligence / Profile preview

Synapsin III (SYN3)

Target
SYN3
Molecular classification
Phosphoprotein, Synaptic vesicle-associated protein, Other (neuron-specific cytoplasmic protein, not an enzyme/receptor/transporter)
01

Overview

Synapsin III is a member of the synapsin family of neuron-specific phosphoproteins found on the cytoplasmic surface of synaptic vesicles[1][2][4]. It shares major conserved domains (A, C, and E) with synapsin I and II, but possesses a unique proline/glutamine-rich domain (J)[1][2]. Its expression is primarily restricted to the brain and neurons, where it is thought to regulate synapse formation and neurotransmitter release[1][2][4]. The SYN3 gene is located on human chromosome 22q12.3, a locus associated with schizophrenia, implicating synapsin III as a candidate gene in neuropsychiatric disease susceptibility[1][2]. Multiple isoforms are generated by alternative splicing. No direct pharmacological targeting or established safety concerns are reported for synapsin III.

Other names
Synapsin-3SYN3Synapsin IIIsynapsin-3cN28H9.2 (synapsin III)
02

Mechanism of action

Not applicable, no known drugs directly targeting SYN3

03

Biological functions

Neurotransmitter releaseSynaptogenesis (formation of synapses)
04

Disease associations

Neuropsychiatric disease (candidate gene for schizophrenia due to chromosomal localization at 22q12–13)Sorsby Fundus DystrophyHereditary Retinal DystrophyOther neurodevelopmental disorders (potential, based on role in neurotransmission)

Beyond the preview

Go deeper on Synapsin III (SYN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synapsin III (SYN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call